Overview
Pap smear examination is a simple and effective screening test used to detect infectious, premalignant, and malignant lesions of the cervix. It plays a crucial role in identifying cervical cancer at an early, treatable stage and helps prevent progression through timely intervention.
The test involves collecting exfoliated cells from the transformation zone of the cervix, where most cervical abnormalities arise. It is an outpatient procedure that is convenient, minimally invasive, and widely used for routine cervical cancer screening.
Symptoms
Pap smear itself is a screening test and is usually performed in asymptomatic women. However, abnormal findings may correlate with symptoms such as abnormal vaginal discharge, intermenstrual or postcoital bleeding, pelvic pain, or foul-smelling discharge. In early premalignant stages, women are often asymptomatic, which makes routine screening essential. Advanced cervical disease may present with persistent bleeding, pain, or systemic symptoms.
Causes
Abnormal Pap smear findings are commonly caused by infections, inflammatory changes, or epithelial cell abnormalities. Persistent infection with high-risk human papillomavirus is the most important cause of premalignant and malignant cervical lesions.
Other causes include bacterial, fungal, or parasitic infections, hormonal changes, atrophy, radiation effects, repair changes, and intrauterine contraceptive device–related alterations. Progression from low-grade to high-grade lesions reflects increasing severity of epithelial dysplasia.
Risk Factors
Early onset of sexual activity, multiple sexual partners, and exposure to high-risk HPV strains increase the risk of abnormal cervical cytology. Immunosuppression, poor genital hygiene, smoking, and low socioeconomic status also contribute to higher risk.
Women who do not undergo regular screening are more likely to present with advanced disease. Long-term use of oral contraceptives and high parity have also been associated with increased risk.
Prevention
Regular Pap smear screening from early adulthood helps detect cervical abnormalities before they progress to cancer. Adhering to recommended screening intervals and ensuring proper sample collection from the transformation zone improves detection rates. HPV vaccination significantly reduces the risk of high-risk HPV infection and subsequent cervical cancer.
Early follow-up, additional testing such as HPV testing or colposcopy, and appropriate management of abnormal results are key to preventing disease progression and reducing cervical cancer burden.
